<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chono</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Katsumata</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Kontani</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kobayashi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Sudo</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Yokota</surname>
    <given-names>T.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2010</year>). 
  <article-title>ASP2151, a novel helicase–primase inhibitor, possesses antiviral activity against varicella–zoster virus and herpes simplex virus types 1 and 2</article-title>. 
  <source>J. Antimicrob. Chemother.</source>
  <volume>65</volume> (
  <issue>8</issue>), 
  <fpage>1733</fpage>–
  <lpage>1741</lpage>. 
  <pub-id pub-id-type="doi">10.1093/jac/dkq198</pub-id>
  <pub-id pub-id-type="pmid">20534624</pub-id>
 </mixed-citation>
</ref>
